by Art Papier, M.D.

Medical errors and startlingly high levels of misdiagnosis have taken a toll on the public’s negative view of our healthcare system. The human costs, mistrust in the system, and economic impact is considerable. According to recent studies, nearly 20% of diagnoses are incorrect. Why such levels? The nature of medical school training, financially driven time pressures put on doctors, a fragmented system, and ever-increasing medical data are part of the problem. There is simply too much to know and certainly too much for any primary care doctor to possibly memorize.

by Douglas Stone
VP of Sales and Marketing

The ability to tailor a patient’s treatment to their own unique genetic makeup is the objective in many disease types. Nowhere is it more evident than in the current treatment of cancer. In 2008, American Cancer Society projects that 1.4 million cancer cases will be diagnosed. Over 600,000 cancer patients will be given chemotherapy but studies show that 70% of cancer patients do not respond to their chemotherapy treatment. Every year, more than $8 billion dollars are spent on costs related to ineffective chemotherapy. These unnecessary costs could have been avoided if therapy selection diagnostics were used before initiating a treatment regimen.

by Mike Reha, Director of Operations
EPIC Hearing Healthcare

Hearing loss is now number three on the list of chronic health problems in our country, and most hearing loss is treatable. It affects over 32 million Americans (1 out of 10) currently with an estimate that this number will double within the next 15 years.